Clinical Trial Update: Efficacy of PRF and MTA as Compared to Calcium Hydroxide for Pulpotomy in Human Irreversibly Inflamed Permanent Teeth [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing PRF and MTA against calcium hydroxide for pulpotomy in irreversibly inflamed permanent teeth; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulpitis Irreversible
• Tooth Decay

Drugs mentioned

• Calcium hydroxide (calcium hydroxide)
• MTA (mineral trioxide aggregate)
• PRF (Platelet-rich fibrin)

Snippet

Sponsor: Liaquat College of Medicine and Dentistry | Conditions: Pulpitis - Irreversible, Tooth Decay | Phase 2 | Status: COMPLETED